Pivotal Study in Nosocomial Pneumonia Suspected or Confirmed to be Due to Pseudomonas
Status:
Terminated
Trial end date:
2019-07-17
Target enrollment:
Participant gender:
Summary
This is a phase 3, multicenter, open-label, sponsor blinded, randomized active-controlled,
parallel group to investigate the efficacy, safety and tolerability of intravenous
murepavadin given with ertapenem versus an anti-pseudomonal β-lactam based antibiotic in the
treatment of nosocomial pneumonia in adult subjects